Dowling & Yahnke LLC Statera Biopharma, Inc. Transaction History

Dowling & Yahnke LLC

  • $215 Million
  • Q3 2022

A detailed history of Dowling & Yahnke LLC transactions in Statera Biopharma, Inc. stock. As of the latest transaction made, Dowling & Yahnke LLC holds 28,875 shares of STAB stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28,875
Previous 28,875 -0.0%
Holding current value
$0
Previous $8,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 04, 2022
BUY
$0.31 - $2.27 $4,402 - $32,234
14,200 Added 96.76%
28,875 $9,000
Q3 2021

Nov 12, 2021
BUY
$2.29 - $6.24 $33,605 - $91,572
14,675 New
14,675 $34,000

Others Institutions Holding STAB

# of Institutions
4
Shares Held
30K
Call Options Held
0
Put Options Held
0
View Full List

About Statera Biopharma, Inc.

STAB Quotes by TradingView
  • Ticker STAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,295,700
  • Description
  • Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. The company is developing therapies designed to directly elicit within ...
More about STAB
Track This Portfolio

Track Dowling & Yahnke LLC Portfolio

Follow Dowling & Yahnke LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dowling & Yahnke LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dowling & Yahnke LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email